AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27150080 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (20 mg oral)
Number of subjects: 43
Study 27150080 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 24332933 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonverbally involved error disclosure (video vignette)
Number of subjects: 216
Study 24332933 — intervention group
Group type: COMPARATOR
Intervention: Nonverbally uninvolved error disclosure (video vignette)
Number of subjects: 216
Study 24666893 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic root canal treatment (BRT) with tactile working length determination
Number of subjects: 0
Study 24666893 — intervention group
Group type: COMPARATOR
Intervention: Standard endodontic treatment with radiographic working length control
Number of subjects: 0
Study 22563844 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference of mathematics training
Number of subjects: 0
Study 22563844 — intervention group
Group type: COMPARATOR
Intervention: Randomized assignment to treatment
Number of subjects: 0
Study 19651669 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm-ergometry
Number of subjects: 41
Study 19651669 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill walking
Number of subjects: 41
Study 19651669 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination (arm-ergometry + treadmill)
Number of subjects: 41
Study 19651669 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 41
Study 17853009 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg/day for 1 month
Number of subjects: 48
Study 17853009 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 15077098 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel and aspirin
Number of subjects: 307
Study 15077098 — intervention group
Group type: COMPARATOR
Intervention: Ticlopidine and aspirin
Number of subjects: 307
Study 12623509 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg/day for 12 months
Number of subjects: 16
Study 12623509 — intervention group
Group type: COMPARATOR
Intervention: Control group (no losartan)
Number of subjects: 16
Study 9656856 — intervention group
Group type: EXPERIMENTAL
Intervention: Iatrosedative interview
Number of subjects: 58
Study 9656856 — intervention group
Group type: COMPARATOR
Intervention: Standard interview
Number of subjects: 58
Study 9656856 — intervention group
Group type: EXPERIMENTAL
Intervention: Iatrosedative interview with same dentist
Number of subjects: 58
Study 9656856 — intervention group
Group type: EXPERIMENTAL
Intervention: Iatrosedative interview with different dentist
Number of subjects: 58
Study 8608285 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretic
Number of subjects: 2584
Study 8608285 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta blocker
Number of subjects: 2584
Study 8608285 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2584
Study 1748138 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg hCT
Number of subjects: 30
Study 1748138 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg hCT
Number of subjects: 30
Study 1748138 — intervention group
Group type: COMPARATOR
Intervention: 100 IU sCT
Number of subjects: 30
Study 1748138 — intervention group
Group type: EXPERIMENTAL
Intervention: hCT and sCT
Number of subjects: 30
Study 1748138 — intervention group
Group type: COMPARATOR
Intervention: sCT
Number of subjects: 30
Study 6763404 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive pharmacotherapy
Number of subjects: 10
Study 6763404 — intervention group
Group type: COMPARATOR
Intervention: Homeopathic treatment
Number of subjects: 10
Study 29067880 — intervention group
Group type: EXPERIMENTAL
Intervention: Loving kindness meditation (LKM) with anodal tDCS applied to right TPJ
Number of subjects: 87
Study 29067880 — intervention group
Group type: COMPARATOR
Intervention: Relaxation control recording with anodal tDCS
Number of subjects: 87
Study 27707789 — intervention group
Group type: EXPERIMENTAL
Intervention: TSO 250
Number of subjects: 252
Study 27707789 — intervention group
Group type: EXPERIMENTAL
Intervention: TSO 2500
Number of subjects: 252
Study 27707789 — intervention group
Group type: EXPERIMENTAL
Intervention: TSO 7500
Number of subjects: 252
Study 27707789 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 252
Study 24807084 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch (HES) 130/0.42
Number of subjects: 804
Study 24807084 — intervention group
Group type: COMPARATOR
Intervention: Ringer's acetate
Number of subjects: 804
Study 21331467 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 481
Study 21331467 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen/paracetamol
Number of subjects: 481
Study 21331467 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 481
Study 19322096 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 0
Study 19322096 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 20-40 mg
Number of subjects: 0
Study 20208238 — intervention group
Group type: EXPERIMENTAL
Intervention: Core Training on guidelines and procedures, didactic diabetes self‐management education, and research protocol training
Number of subjects: 542
Study 20208238 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental training utilizing participatory methods
Number of subjects: 542
Study 15301218 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel oral water irrigator
Number of subjects: 35
Study 15301218 — intervention group
Group type: COMPARATOR
Intervention: Conventional electric toothbrush
Number of subjects: 35
Study 11275936 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic polymorphisms of the renin-angiotensin-aldosterone system (RAAS) including ACE, AGTR1, AGT, CMA, CYP11B2
Number of subjects: 105
Study 9789474 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled steroids
Number of subjects: 2
Study 9789474 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisone
Number of subjects: 2
Study 8014724 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratified life-expectancy data
Number of subjects: 330
Study 8014724 — intervention group
Group type: COMPARATOR
Intervention: Averaged life-expectancy data
Number of subjects: 330
Study 8014724 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost increase (tenfold)
Number of subjects: 330
Study 8014724 — intervention group
Group type: COMPARATOR
Intervention: Cost-effectiveness criteria
Number of subjects: 330
Study 1809419 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotically recalled anger
Number of subjects: 12
Study 1809419 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotically recalled fear
Number of subjects: 12
Study 1809419 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotically recalled depression
Number of subjects: 12
Study 1809419 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotically recalled happy
Number of subjects: 12
Study 1809419 — intervention group
Group type: COMPARATOR
Intervention: Neutral hypnotic control condition
Number of subjects: 12
Study 1809419 — intervention group
Group type: COMPARATOR
Intervention: Posthypnotic awake control condition
Number of subjects: 12
Study 1809419 — intervention group
Group type: COMPARATOR
Intervention: Prehypnotic baseline condition
Number of subjects: 12
Study 6218097 — intervention group
Group type: EXPERIMENTAL
Intervention: mezlocillin (4 g 6-hourly)
Number of subjects: 80
Study 6218097 — intervention group
Group type: COMPARATOR
Intervention: carbenicillin (5 g 4-hourly)
Number of subjects: 80
Study 30660371 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of lavender oil
Number of subjects: 80
Study 30660371 — intervention group
Group type: COMPARATOR
Intervention: Control group (no lavender oil)
Number of subjects: 80
Study 28930494 — intervention group
Group type: EXPERIMENTAL
Intervention: Momelotinib 200 mg once daily
Number of subjects: 432
Study 28930494 — intervention group
Group type: COMPARATOR
Intervention: Ruxolitinib 20 mg twice a day
Number of subjects: 432
Study 27538757 — intervention group
Group type: EXPERIMENTAL
Intervention: PREPARE (physiotherapeutic prehabilitation program based on a cognitive behavioural approach)
Number of subjects: 110
Study 27538757 — intervention group
Group type: EXPERIMENTAL
Intervention: PREPARE (physiotherapeutic prehabilitation program)
Number of subjects: 110
Study 27538757 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 110
Study 23838316 — intervention group
Group type: EXPERIMENTAL
Intervention: OCDC vaccine (dendritic cells pulsed with HOCl-oxidized autologous tumor lysate)
Number of subjects: 5
Study 21219979 — intervention group
Group type: EXPERIMENTAL
Intervention: Pandemic (H1N1) 2009 vaccine containing 7.5 μg of hemagglutinin (HA)
Number of subjects: 474
Study 21219979 — intervention group
Group type: EXPERIMENTAL
Intervention: Pandemic (H1N1) 2009 vaccine containing 15 μg of hemagglutinin (HA)
Number of subjects: 474
Study 21219979 — intervention group
Group type: EXPERIMENTAL
Intervention: Second dose of A H1N1 vaccine
Number of subjects: 474
Study 21219979 — intervention group
Group type: COMPARATOR
Intervention: Pandemic (H1N1) 2009 vaccine formulations
Number of subjects: 474
Study 19809382 — intervention group
Group type: EXPERIMENTAL
Intervention: Postchemotherapy tumor gene signatures (T2)
Number of subjects: 47
Study 19809382 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy-induced relative change signatures (TDelta)
Number of subjects: 47
Study 19809382 — intervention group
Group type: COMPARATOR
Intervention: Baseline tumor gene signatures (T1)
Number of subjects: 47
Study 17325142 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% atropine drops
Number of subjects: 233
Study 17325142 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% cyclopentolate and 0.5% tropicamide
Number of subjects: 233
Study 17325142 — intervention group
Group type: COMPARATOR
Intervention: 1% cyclopentolate
Number of subjects: 233
Study 14769568 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention designed to improve compliance with evidenced-based guidelines of central venous catheter management.
Number of subjects: 4489
Study 14769568 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention
Number of subjects: 4489
Study 12324295 — intervention group
Group type: EXPERIMENTAL
Intervention: Flour fortified with iron only (60 mg Fe/kg)
Number of subjects: 90
Study 12324295 — intervention group
Group type: EXPERIMENTAL
Intervention: Flour cofortified with zinc sulfate (60 mg Zn/kg)
Number of subjects: 90
Study 12324295 — intervention group
Group type: EXPERIMENTAL
Intervention: Flour cofortified with zinc oxide (60 mg Zn/kg)
Number of subjects: 90
Study 12324295 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc sulfate cofortified flour
Number of subjects: 90
Study 12324295 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc oxide cofortified flour
Number of subjects: 90
Study 9880768 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined modality therapy with radioisotope implantation
Number of subjects: 0
Study 9880768 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative radiation therapy (IORT)
Number of subjects: 0
Study 9880768 — intervention group
Group type: EXPERIMENTAL
Intervention: New chemotherapeutic agents
Number of subjects: 0
Study 9880768 — intervention group
Group type: COMPARATOR
Intervention: Postoperative adjuvant therapy
Number of subjects: 0
Study 9880768 — intervention group
Group type: COMPARATOR
Intervention: More aggressive regimens
Number of subjects: 0
Study 7976093 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol
Number of subjects: 24
Study 7976093 — intervention group
Group type: COMPARATOR
Intervention: Clobetasol propionate 0.05%
Number of subjects: 24
Study 3384245 — intervention group
Group type: EXPERIMENTAL
Intervention: DVI mode
Number of subjects: 23
Study 3384245 — intervention group
Group type: COMPARATOR
Intervention: VVI mode
Number of subjects: 23
Study 3384245 — intervention group
Group type: EXPERIMENTAL
Intervention: DVI mode (Group A)
Number of subjects: 23
Study 3384245 — intervention group
Group type: COMPARATOR
Intervention: VVI mode (Group A)
Number of subjects: 23
Study 31194613 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib 150 mg/d (neoadjuvant therapy for 42 days; adjuvant therapy for up to 12 months)
Number of subjects: 72
Study 31194613 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine 1,250 mg/m2 plus cisplatin 75 mg/m2 (neoadjuvant therapy for two cycles; adjuvant therapy for up to two cycles)
Number of subjects: 72
Study 31194613 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib
Number of subjects: 72
Study 31194613 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine plus cisplatin
Number of subjects: 72
Study 28286331 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient direct access to physiotherapy pathway
Number of subjects: 978
Study 28286331 — intervention group
Group type: COMPARATOR
Intervention: Usual GP-led care
Number of subjects: 978
Study 25395381 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based educational program
Number of subjects: 9
Study 25395381 — intervention group
Group type: COMPARATOR
Intervention: Text and video materials
Number of subjects: 9
Study 25395381 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 9
Study 23270749 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium polyaspartate-containing anti-stain dentifrice
Number of subjects: 0
Study 23270749 — intervention group
Group type: COMPARATOR
Intervention: Standard fluoride dentifrice
Number of subjects: 0
Study 21521254 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide LAR 20 mg every 28th day for 6 months
Number of subjects: 32
Study 21521254 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute octreotide test
Number of subjects: 32
Study 21521254 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide treatment
Number of subjects: 32
Study 18644399 — intervention group
Group type: EXPERIMENTAL
Intervention: HYPO (hypohydrated by 2% body mass)
Number of subjects: 12
Study 18644399 — intervention group
Group type: EXPERIMENTAL
Intervention: HYPO
Number of subjects: 12
Study 18644399 — intervention group
Group type: COMPARATOR
Intervention: EUH (euhydrated)
Number of subjects: 12
Study 16925701 — intervention group
Group type: EXPERIMENTAL
Intervention: Pledget soaked in mydriatics placed in the inferior fornix for 20 min
Number of subjects: 56
Study 16925701 — intervention group
Group type: COMPARATOR
Intervention: Control eye drops (tropicamide, phenylepherine, atropine) administered as routine practice
Number of subjects: 56
Study 16925701 — intervention group
Group type: EXPERIMENTAL
Intervention: Pledget soaked in mydriatics
Number of subjects: 56
Study 16925701 — intervention group
Group type: COMPARATOR
Intervention: Control eye drops
Number of subjects: 56
Study 12928052 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-1B +3953 CT or TT genotypes
Number of subjects: 0
Study 12928052 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-1B +3953 CT or TT genotypes with IL-1A -889 TT genotype
Number of subjects: 0
Study 10722780 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine supplementation (GLN)
Number of subjects: 7
Study 10722780 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment (PLA)
Number of subjects: 7
Study 9534367 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothbrush A
Number of subjects: 25
Study 9534367 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothbrush B
Number of subjects: 25
Study 9534367 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothbrush C
Number of subjects: 25
Study 1585957 — intervention group
Group type: EXPERIMENTAL
Intervention: Prepaid plans
Number of subjects: 0
Study 1585957 — intervention group
Group type: COMPARATOR
Intervention: Traditional Medicaid
Number of subjects: 0
Study 3979676 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (20 mg/kg/24 h)
Number of subjects: 34
Study 3979676 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 29762252 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 32
Study 29762252 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 32
Study 27224474 — intervention group
Group type: EXPERIMENTAL
Intervention: CD64-guided group (antibiotics prescribed based on CD64 index)
Number of subjects: 0
Study 27224474 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment group (antibiotics prescribed based on experience and clinical symptoms)
Number of subjects: 0
Study 25439711 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsychosocial prevention program (n=75) addressing playing-related health problems and providing postural training according to Mensendieck or Cesar methods.
Number of subjects: 150
Study 25439711 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=75) participating in a program that stimulates a healthy physical activity level using a pedometer.
Number of subjects: 150
Study 21979149 — intervention group
Group type: EXPERIMENTAL
Intervention: Approach‐Avoidance Task (AAT)
Number of subjects: 34
Study 21979149 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=49)
Number of subjects: 34
Study 19736368 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized L-epinephrine
Number of subjects: 62
Study 19736368 — intervention group
Group type: COMPARATOR
Intervention: Budesonide
Number of subjects: 62
Study 17606774 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed amphetamine salts extended release (MAS‐XR; Adderall)
Number of subjects: 0
Study 17606774 — intervention group
Group type: COMPARATOR
Intervention: Atomoxetine (Strattera)
Number of subjects: 0
Study 16207775 — intervention group
Group type: EXPERIMENTAL
Intervention: Violent video game exposure (VVE)
Number of subjects: 0
Study 16207775 — intervention group
Group type: COMPARATOR
Intervention: Nonviolent video game exposure
Number of subjects: 0
Study 16207775 — intervention group
Group type: EXPERIMENTAL
Intervention: High VVE
Number of subjects: 0
Study 16207775 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediational factors (trait hostility, empathy, hostile perceptions)
Number of subjects: 0
Study 11854876 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-bonded cardiopulmonary bypass (HB-CPB)
Number of subjects: 61
Study 11854876 — intervention group
Group type: COMPARATOR
Intervention: Nonheparin-bonded cardiopulmonary bypass (NH-CPB)
Number of subjects: 61
Study 10407202 — intervention group
Group type: EXPERIMENTAL
Intervention: Face with opened eyes
Number of subjects: 0
Study 10407202 — intervention group
Group type: EXPERIMENTAL
Intervention: Face with closed eyes
Number of subjects: 0
Study 10407202 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyes
Number of subjects: 0
Study 10407202 — intervention group
Group type: EXPERIMENTAL
Intervention: Scrambled face
Number of subjects: 0
Study 10407202 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand
Number of subjects: 0
Study 10407202 — intervention group
Group type: EXPERIMENTAL
Intervention: MEG recording
Number of subjects: 0
Study 10407202 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG recording
Number of subjects: 0
Study 7566580 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous calcitriol (0.045 micrograms/kg/weekly)
Number of subjects: 26
Study 7566580 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent oral calcitriol (0.045 micrograms/kg/weekly)
Number of subjects: 26
Study 7566580 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily oral calcitriol (0.045 micrograms/kg/weekly)
Number of subjects: 26
Study 1981436 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical clindamycin phosphate 1% twice daily
Number of subjects: 66
Study 1981436 — intervention group
Group type: COMPARATOR
Intervention: Oral minocycline 50 mg twice daily
Number of subjects: 66
Study 7029294 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 drugs (vincristine, dactinomycin, cyclophosphamide, adriamycin)
Number of subjects: 251
Study 7029294 — intervention group
Group type: COMPARATOR
Intervention: 3 drugs (vincristine, dactinomycin, cyclophosphamide)
Number of subjects: 251
Study 7029294 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 drugs and bilateral pulmonary irradiation (approximately 1,500 rad in 2 weeks)
Number of subjects: 251
Study 7029294 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy (RT) doses to the primary tumor
Number of subjects: 251
Study 7029294 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with lesions in the pelvis
Number of subjects: 251
Study 7029294 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with lesions in the humerus
Number of subjects: 251
Study 30939480 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment group (systolic blood pressure target of < 120 mm Hg)
Number of subjects: 9361
Study 30939480 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment group (systolic blood pressure target of < 140 mm Hg)
Number of subjects: 9361
Study 27124589 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time feedback (RTF) via touch screens installed in waiting areas for 12 weeks, with practice staff encouraging participation.
Number of subjects: 0
Study 27124589 — intervention group
Group type: EXPERIMENTAL
Intervention: Costs associated with implementing RTF in practices.
Number of subjects: 0
Study 25919263 — intervention group
Group type: EXPERIMENTAL
Intervention: Active pulsed electromagnetic field therapy
Number of subjects: 32
Study 25919263 — intervention group
Group type: COMPARATOR
Intervention: Sham pulsed electromagnetic field therapy
Number of subjects: 32
Study 24067390 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive pill (OCP) users
Number of subjects: 100
Study 24067390 — intervention group
Group type: COMPARATOR
Intervention: Non-OCP users
Number of subjects: 100
Study 21851939 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole (2.5 mg on cycle days 3-7)
Number of subjects: 15
Study 21851939 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (50 mg on cycle days 5-9)
Number of subjects: 15
Study 21851939 — intervention group
Group type: COMPARATOR
Intervention: Fertile ovulatory women (control group)
Number of subjects: 15
Study 19525519 — intervention group
Group type: EXPERIMENTAL
Intervention: sirolimus 2 mg/day
Number of subjects: 50
Study 19525519 — intervention group
Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 50
Study 17200148 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 4922